Sign-up to Receive
Our Latest Insights

CURE
VanEck Genomics and Healthcare Innovators UCITS ETF

Fund Description

Technology is transforming healthcare. Not only are genomic treatments for several diseases becoming more affordable, but also digitalized healthcare is growing fast. VanEck’s Genomics and Healthcare Innovators UCITS ETF invests in the businesses pioneering ways to treat disease and connect with patients.

  • Invest in genomics companies developing new ways to treat health problems such as genetic conditions, cancer and conditions related to ageing
  • Gain exposure to digital health services providers – delivering easy access to doctors, physiotherapists, nurses and pharmacists
  • Pure-play exposure to companies earning at least half their revenues from genomics- or e-healthcare-related industries
  • Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco


Risk: You may lose money up to the total loss of your investment due to the Main Risk Factors such as Equity Market Risk and Industry Concentration Risk described below in the KID and in the sales prospectus. Evolving of the market not guaranteed.



Underlying Index

MVIS® Global Future Healthcare ESG Index (MVFHCTR)

Fund Details
 

  • Fund Ticker

    CURE
  • Management Company

    VanEck Asset Management B.V.
  • Custodian

    State Street Custodial Services (Ireland) Limited
  • Domicile

    Ireland
  • UCITS Compliant

    Yes
  • Index Ticker

    MVFHCTR
  • Index Provider

    MarketVector Indexes
  • Rebalance Frequency

    Semi-Annually
1The "Net Asset Value" (NAV) of all ETFs is determined at the close of each business day, and represents the value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF 's intraday trading value. Investors should not expect to buy or sell ETF shares at NAV.

2The date the fund was launched prior to quotation on the stock exchange.

 
as of 07 Feb 2023

  • NAV1

    21.86
  • Shares Outstanding

    310,000
  • Number of Holdings

    57
  • Base Currency

    USD
  • Net Assets

    $6.8M
  • Product Structure

    Physical (Full Replication)
  • Income Treatment

    Reinvestment
  • Distribution Frequency

    None
  • Total Expense Ratio

    0.35%
  • SFDR Classification

    Article 8
  • Fact Sheet
  • Fund Holiday Calendar

Trading Information as of 07 Feb 2023

Deutsche
Börse
EUR
Exchange Ticker CURE
ISIN IE000B9PQW54
SEDOL BNG7JX1
Bloomberg CURE GY
Reuters (RIC) CURE.DE
Valor 121031038
Bloomberg iNAV CUREUSIV
Reuters iNAV CUREINAV=SOLA
WKN A3DSGJ
Trading Currency EUR
Last Traded Price 20.23
Day's Move -0.24
Volume 7
30 Day Volume 233
VWAP Volume 7

NAVs as of 07 Feb 2023

Base
Currency
NAV Daily
Change
NAV
YTD
Change
NAV
NAV Price
History
Total
Expense
Ratio
CURE USD $21.86 $0.24 / +1.12% +4.23%
0.35

Performance History* (%)

  1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVFHCTR (Index) 3.94 4.46 3.94 -8.57 -- -- -- 8.28
  1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVFHCTR (Index) -4.19 8.94 -24.99 -24.99 -- -- -- 4.11
  2018 2019 2020 2021 2022
MVFHCTR (Index) -- -- -- -- -24.99

Market Makers

Top 10 Holdings (%) as of 31 Jan 2023 View All Holdings »

Total Holdings: 57
Swipe<br>to view <br> full data
Holding Name
Ticker
Shares Market Value
(USD)
% of Net
Assets
VERTEX PHARMACEUTICALS INC VRTX US 1,696 547,978 8.10
MODERNA INC MRNA US 3,009 529,765 7.83
REGENERON PHARMACEUTICALS INC REGN US 617 467,976 6.92
ILLUMINA INC ILMN US 1,937 414,905 6.13
DEXCOM INC DXCM US 3,711 397,411 5.87
VEEVA SYSTEMS INC VEEV US 2,036 347,240 5.13
BIONTECH SE BNTX US 2,277 326,545 4.83
ALNYLAM PHARMACEUTICALS INC ALNY US 1,309 296,358 4.38
M3 INC 2413 JP 9,900 266,979 3.95
QIAGEN NV QGEN US 4,701 230,349 3.41
Top 10 Total (%) 56.55
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 31 Jan 2023

  • Country

    % of Net Assets
  • United States

    79.28
  • China

    6.77
  • Germany

    5.61
  • Japan

    3.95
  • United Kingdom

    1.45
  • Switzerland

    1.19
  • Australia

    0.93
  • Sweden

    0.47
  • Netherlands

    0.29
  • Other/Cash

    0.06

Sector Weightings (%) as of 31 Jan 2023

  • Sector

    % of Net Assets
  • Health Care

    94.0
  • Consumer Discretionary

    5.4
  • Consumer Staples

    0.3
  • Materials

    0.3
  • Other/Cash

    0.1

Discover more ETFs

More ETFs